InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Browse the detailed record of transactions filed by Bedrosian Camille L. Insider active across 1 companies, notably Ultragenyx Pharmaceutical Inc.. Cumulatively, 9 disclosures have been logged. Total volume traded: €483k. The latest transaction was disclosed on 1 March 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€167,5612,821 shares@ €59.39770.0068% mcap23.4% of flow
Common Stock
SEC:0001209191-22-015802:0·
€98,5551,657 shares@ €59.47770.0040% mcap13.8% of flow
Common Stock
SEC:0001209191-22-005838:0·
€98,5551,657 shares@ €59.47770.0040% mcap36.0% of flow
Common Stock
SEC:0001209191-22-005838·
€25,130359 shares@ €69.99950.0010% mcap9.2% of flow
Common Stock
SEC:0001209191-21-060765·
€25,130359 shares@ €69.99950.0010% mcap3.5% of flow
Common Stock
SEC:0001209191-21-060765:0·
€116,1232,500 shares@ €46.44910.0047% mcap42.4% of flow
Common Stock
SEC:0001209191-21-054542·
€116,1232,500 shares@ €46.44910.0047% mcap16.2% of flow
Common Stock
SEC:0001209191-21-054542:0·
€34,284364 shares@ €94.1870.0014% mcap12.5% of flow
Common Stock
SEC:0001209191-21-031376·
€34,284364 shares@ €94.1870.0014% mcap4.8% of flow
Common Stock
SEC:0001209191-21-031376:0·
9 of 9 declarations
About Bedrosian Camille L
Camille L Bedrosian is a director at Ultragenyx Pharmaceutical Inc.
